Alexandra Bream

Market Analyst

Alex joined Signify research in 2023 as a market analyst in the diagnostics and life sciences area. In summer 2023, Alex graduated from the University of Birmingham with a first-class degree in Biochemistry. At University Alex was the president for the Women in Science and Engineering society and is a big advocate for this. In Alex’s spare time she likes cooking and enjoys travelling.

The latest from Alexandra Bream

Insight
21 Jun 2024: Diagnostics and Lifesciences
Business Analytics – Why does your LIMS/ LIS need it?
Laboratory information management systems (LIMS) and Laboratory information systems (LIS) are software solutions designed to manage sample and patient data respectively.
Arrow Right
Insight
24 May 2024: Diagnostics and Lifesciences, Healthcare IT, Market Reports
How Should Healthcare Technology Vendors Invest in Precision Medicine?
Digital precision medicine is a spectrum, which in our infographic we have illustrated in a pyramidPrecision medicine as a concept exists along a spectrum; as more data is used to inform a patient’s journey we advance further and further into true ‘personalisation’.
Arrow Right
Market Intelligence Reports
30 Sep 2024: Diagnostics and Lifesciences, Market Reports
Laboratory Information Systems – World – 2024
This is the second iteration of our Market Report on the global market for Laboratory Information...
Arrow Right
Insight
06 Feb 2024: Diagnostics and Lifesciences
Digital Twins: The Mirror to the Future
Signify Research explores the drivers and barriers related to deploying ‘Digital Twin’ software in healthcare environments, as well as the market dynamics and projected growth for different approaches that can be taken.
Arrow Right
Insight
11 Nov 2023: Diagnostics and Lifesciences
Destination DICOM in Digital Pathology: Drivers and Obstacles
Digital pathology may have been a nascent sector historically, but sudden growth in the market since 2020 has sparked attention from both pathology and wider healthcare stakeholders. 
Arrow Right